Drug Delivery Faculty Starter Grant
Funds early-career faculty for innovative, translational research in drug delivery technologies to optimize drug composition, dosage, and delivery for improved patient outcomes.
Funder: PhRMA Foundation
Due Dates: April 15, 2026: Letter of Intent deadline (LOI) | August 26, 2026: Full application deadline (by invitation)
Funding Amounts: $100,000 for one year; no salary or indirect costs allowed; funds must directly support research.
Summary: Supports early-career faculty for innovative, translational research in drug delivery technologies to improve patient treatment outcomes.
Key Information: Two-step process: LOI required for full application invitation; strict eligibility and funding restrictions apply.
Description
This program funds early-career faculty beginning independent research careers in drug delivery at accredited U.S. universities. The goal is to support innovative and therapeutically relevant research that optimizes drug composition, dosage, and delivery to enhance clinical viability, safety, efficacy, and patient management. Projects may focus on formulation development, delivery technologies, CMC processes for challenging chemical entities, or predictive modeling approaches that connect drug quality attributes with in vivo performance. Proposals must have a defined therapeutic payload, target tissue, and dosing rationale, with translational validation plans if computational methods are used.
